Healthcare

>

Biotechnology

>

OTC:
EMMLF

OKYO PHARMA LTD

Recent publications about $EMMLF

OKYO Pharma Limited – PDMR Dealing

LONDON and BOSTON, May 20, 2022 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), a life sciences company focused on the discovery and

OKYO Pharma Limited – PDMR Dealing

LONDON and NEW YORK, May 18, 2022 (GLOBE NEWSWIRE) — OKYO Pharma Limited (LSE: OKYO; NASDAQ: OKYO), a biotechnology company focused on the discovery and

Register by Email

or
Already a member? Sign In